← Evidence map

ArticleFrontiers in immunology2022

The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM.

Wancong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36211371